Utilidad del PET-RNM cerebral en la reestadificación de un cáncer de sigmoides con metástasis cerebrales


  1. Cante D, Girelli G, La Porta MR, et al. Late brain metastases from colorectal cancer. A case report and review of the literature. Tumori 20015;91:280-2.
  2. Andrea G, Isidori A, Caroli E, et al. Single cerebral metastasis from colorectal adenocarcinoma. Neurosurg Rev 2004;27:55-7.
  3. Metástasis cerebral de adenocarcinoma colónico. Rev Esp Dig 2009;101:221-2.
  4. Ruiz-Hernandez G, Burzaco JA, Montz R, et al. PET-RNM en paciente con hidrocefalia y metástasis tratadas con radiocirugía. Oncología 2002;25:54-8.
  5. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain. A randomized trial. JAMA 1998;280:1485-9.
  6. Kondziolka D, Patel A, Lundsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999;45:427-34.
  7. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665-72.
  8. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA 2006;295:2483-91.
  9. Gang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery o radiosurgery plus whole brain irradiation: a randomized controlled trial. Lancet Oncol 2009;10:1037-44.
  10. Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole brain radiotherapy following versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases: Results of the EORTC 22952-26002 study. J Clin Oncol 2011;29:134-41.
  11. Metha MP, Tsao MN, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology ( ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005;63:37-46.
  12. Maranzano E, Trippa F, Pacchiarini D, er al. Re-irradiation of brain metastases and metastatic spinal cord compression: clinical practice suggestions. Tumori 2005;91:325-30.
  13. Bahl A, Kumar M, Sharma D, et al. Reirradiation for progressive brain metastases. J Cancer Res Ther 2009;5:161-4.
  14. Chao S, Barnett GH, Vogelbaum MA, et al. Salvage stereotactic radiosurgery effectively treats recurrences from whole brain radiation therapy. Cancer 2008;113:2198-204.
  15. Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 2008;70:1350-60.
  16. Chen W. Clinical applications of PET in brain tumors. J Nucl Med 2007;48:1468-81.
  17. Belohlávek O, Simonova G, Kantorova I, et al. Brain metastases alter stereotactic radiosurgery using Leksell gamma Knife: can FDG PET help to differentiate radionecrosis from tumor progression? Eur J Nucl Med 2003;30:96-100.
  18. Tan H, Chen L, Guan Y, et al. Comparison of MRI, F-18 FDG and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy. Clin Nucl Med 2011;36:978-81.
  19. Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, et al. Differentiation between brain tumor and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy. Folia Neuropathol 2010;48:81-92.
  20. Kano H, Kondziolka D, Lobato-Polo J, et al. T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosugery 2010;66:486-92.